Free Trial
NASDAQ:MLTX

MoonLake Immunotherapeutics Q1 2025 Earnings Report

MoonLake Immunotherapeutics logo
$44.87 +1.37 (+3.15%)
Closing price 06/23/2025 04:00 PM Eastern
Extended Trading
$44.60 -0.27 (-0.60%)
As of 07:26 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MoonLake Immunotherapeutics EPS Results

Actual EPS
-$0.63
Consensus EPS
-$0.76
Beat/Miss
Beat by +$0.13
One Year Ago EPS
-$0.22

MoonLake Immunotherapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

MoonLake Immunotherapeutics Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

MoonLake Immunotherapeutics' Q1 2025 earnings is scheduled for Wednesday, August 6, 2025

Earnings Documents

MoonLake Immunotherapeutics Earnings Headlines

12 “perfect” stocks
Join the Dream Team and see how we can guarantee stock market wins Credentials are a good thing, especially when it has to do with your money... And your financial future. But the team of expert Editors at Zacks aren't called the "Investing Dream Team"...
See More MoonLake Immunotherapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like MoonLake Immunotherapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on MoonLake Immunotherapeutics and other key companies, straight to your email.

About MoonLake Immunotherapeutics

MoonLake Immunotherapeutics (NASDAQ:MLTX), a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was incorporated in 2020 and is headquartered in Zug, Switzerland.

View MoonLake Immunotherapeutics Profile

More Earnings Resources from MarketBeat